Ac. Haglund et al., Alteration of the fibrinogen molecule and its phosphorylation state in myocardial infarction patients undergoing thrombolytic treatment, THROMB RES, 98(2), 2000, pp. 147-156
Fibrinogen was purified by protamine-agarose chromatography from plasma fro
m three patients after their submission to hospital due to acute myocardial
infarction, The total amount of phosphate bound to fibrinogen and the conc
entration of fibrinogen was determined in samples withdrawn immediately aft
er submission and after thrombolytic treatment. Streptokinase treatment alm
ost totally removed circulating fibrinogen while recombinant tissue plasmin
ogen activator spared much of it. In patients treated with streptokinase, t
he new circulating fibrinogen was homogenous according to the single alpha-
band seen after sodium dodecyl sulphate polyacrylamide gel electrophoresis
analysis under reducing conditions, whereas fibrinogen from the recombinant
tissue plasminogen activator-treated patient as well as healthy controls e
xhibited two alpha-bands in the 66-kDa region. The molar ratios of phosphat
e to fibrinogen of healthy controls and commercial fibrinogen were 0.82 (+/
- 0.04) and 0.87 (+/- 0.05), respectively. For two streptokinase-treated pa
tients the degree of phosphorylation increased threefold from a normal rang
e of 0.97 (+/- 0.11) and 0.67 (+/- 0.09) mol/mol fibrinogen before treatmen
t to 3.33 (+/- 0.32) and 1.86 (+/- 0.17) mol/mol in newly formed fibrinogen
on day 1. Recombinant tissue plasminogen activator treatment led to a smal
ler increase in phosphorylation, from 1.14 (+/- 0.13) pretreatment to 1.65
(+/- 0.11) after treatment on day 1. In conclusion Eye show in this report
that after streptokinase treatment of patients with acute myocardial infarc
tion, the new Aa-chain of fibrinogen was a homogenous single 66-kDa band on
sodium dodecyl sulphate polyacrylamide gel electrophoresis under reducing
conditions and that the degree of phosphorylation of plasma fibrinogen was
elevated, approaching the theoretical limit of 4 mol phosphate/mol fibrinog
en. (C) 2000 Elsevier Science Ltd. All rights reserved.